These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1378618)

  • 1. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
    Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
    Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses.
    Oshima M; Atassi MZ
    Autoimmunity; 2000; 32(1):45-55. PubMed ID: 10958175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.
    Hohlfeld R; Toyka KV; Tzartos SJ; Carson W; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5379-83. PubMed ID: 2955417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M; Ostlie N; Lei S; Conti-Tronconi BM
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.
    Barchan D; Souroujon MC; Im SH; Antozzi C; Fuchs S
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8086-91. PubMed ID: 10393952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor.
    Bartfeld D; Fuchs S
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):4006-10. PubMed ID: 279016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    Rosenberg JS; Oshima M; Atassi MZ
    J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenic role of acetylcholine receptor alpha chain epitope within alpha 146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice.
    Shenoy M; Goluszko E; Christadoss P
    Clin Immunol Immunopathol; 1994 Dec; 73(3):338-43. PubMed ID: 7955562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides.
    Atassi MZ; Oshima M
    Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.
    Venkatesh N; Im SH; Balass M; Fuchs S; Katchalski-Katzir E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):761-6. PubMed ID: 10639153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products.
    Oshima M; Yokoi T; Deitiker P; Atassi MZ
    Autoimmunity; 1998; 27(2):79-90. PubMed ID: 9583739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of the regions of acetylcholine receptor alpha chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor.
    Oshima M; Pachner AR; Atassi MZ
    Mol Immunol; 1994 Aug; 31(11):833-43. PubMed ID: 7519305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
    Katz-Levy Y; Kirshner SL; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7000-4. PubMed ID: 7688469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors that determine the severity of experimental myasthenia gravis.
    Drachman DB; McIntosh KR; Yang B
    Ann N Y Acad Sci; 1998 May; 841():262-82. PubMed ID: 9668247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.